Dyson J E, Watkinson A P, Jones W G, Corbett P J, Joslin C A
Br J Cancer. 1980 Sep;42(3):448-54. doi: 10.1038/bjc.1980.257.
A double-blind trial of the tanned-erythrocyte electrophoretic mobility test for cancer has been carried out. This included 70 normal subjects as controls, 61 subjects with disease other than cancer, and 229 cancer patients. Slowing values generally increased in the order given, with certain diseases having values within the range positive for cancer. Exposure to viral infection also tended to produce false positives. Slowing values above 50%, however, appear to be definitely associated with cancer. For the middle range of slowing values (25-50%) there is some overlap between the 3 groups, so that a statistical probability of the presence of malignancy is available from the test. With slowing values below 25% there is little likelhood of cancer. Tumour type influences the test result, as does, to a lesser extent, tumour bulk.
已对用于癌症检测的鞣酸红细胞电泳迁移率试验进行了双盲试验。该试验包括70名正常受试者作为对照组，61名患有非癌症疾病的受试者，以及229名癌症患者。减慢值通常按上述顺序增加，某些疾病的数值在癌症阳性范围内。接触病毒感染也往往会产生假阳性。然而，减慢值超过50%似乎肯定与癌症有关。对于减慢值的中间范围（25%-50%），三组之间存在一些重叠，因此该试验可得出存在恶性肿瘤的统计概率。减慢值低于25%时，患癌症的可能性很小。肿瘤类型会影响检测结果，肿瘤大小在较小程度上也会影响检测结果。
